Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BIOC

Biocept (BIOC) Stock Price, News & Analysis

Biocept logo

About Biocept Stock (NASDAQ:BIOC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.43
$1.67
52-Week Range
N/A
Volume
751,400 shs
Average Volume
764,067 shs
Market Capitalization
$1.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BIOC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biocept and its competitors with MarketBeat's FREE daily newsletter.

BIOC Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

BIOC Stock Analysis - Frequently Asked Questions

Biocept, Inc. (NASDAQ:BIOC) released its quarterly earnings results on Monday, November, 15th. The medical research company reported $0.90 earnings per share for the quarter, missing the consensus estimate of $2.70 by $1.80. The medical research company earned $17.47 million during the quarter, compared to analysts' expectations of $16.87 million.

Biocept shares reverse split before market open on Wednesday, May 17th 2023.The 1-30 reverse split was announced on Wednesday, May 17th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, May 17th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biocept investors own include Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), T2 Biosystems (TTOO), VBI Vaccines (VBIV), Vaxart (VXRT), NIO (NIO) and iBio (IBIO).

Company Calendar

Last Earnings
11/15/2021
Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
NASDAQ:BIOC
CIK
1044378
Employees
50
Year Founded
1993

Profitability

EPS (Trailing Twelve Months)
($58.4549)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$32.09 million
Net Margins
N/A
Pretax Margin
-564.02%
Return on Equity
-468.87%
Return on Assets
-118.41%

Debt

Debt-to-Equity Ratio
2.88
Current Ratio
1.81
Quick Ratio
1.70

Sales & Book Value

Annual Sales
$25.86 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$15.60 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,630,000
Free Float
2,584,000
Market Cap
$1.14 million
Optionable
Not Optionable
Beta
0.69

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:BIOC) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners